Climate Change Data

Kobayashi Pharmaceutical Co., Ltd.

Climate Impact & Sustainability Data (2020, 2021, 2022)

Reporting Period: 2020

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:1794 tons in 2020 (21% decrease from previous year)
Carbon Intensity:0.124 t-CO2/million yen in 2020

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Reduced CO2 emissions by 24% per unit of sales vs. fiscal 2005/3
  • Achieved medium-term targets for recycling at all factories in 2020
  • 99.8% recycling rate

Social Achievements

  • Launched and established portfolio of products with eco labeling
  • Implemented work-style reforms
  • Continued to use Diversity Index

Governance Achievements

  • Established a dedicated ESG department
  • Enhanced discussions on medium-term management plan, sustainability, risks, and capital productivity
  • Board of Directors reforms

Climate Goals & Targets

Long-term Goals:
  • Consolidated net sales of ¥280 billion, of which ¥90 billion will originate from markets outside of Japan by 2030
Medium-term Goals:
  • Achieve a four-year contribution rate of new products of 20% or more
  • 54.6% reduction in Group’s total CO2 emissions from 2017 levels by 2030
  • Double production per worker by 2030
Short-term Goals:
  • Establish four new products in the market each year

Environmental Challenges

  • Lower utilization rates caused by the COVID-19 pandemic worsened emissions per unit of sales.
  • Weaker inbound tourism demand and economic stagnation caused by COVID-19.
  • Risks of greenhouse gas-related regulations, reduced demand for some product sectors, and dramatic increases in the price of raw materials.
Mitigation Strategies
  • Energy-saving measures in our offices and manufacturing upgrades.
  • Developed products after confirming whether raw materials can be used in China, and whether these products can be used in China’s living environment.
  • Took appropriate measures to address each risk and opportunity identified through climate change scenario analysis.

Supply Chain Management

Supplier Audits: Survey of 40 major suppliers of raw materials to assess the risk of human rights violations in 2020

Responsible Procurement
  • Kobayashi Pharmaceutical Basic Procurement Policy
  • Policies on strengthening respect for human rights and fulfilling our corporate social responsibilities

Climate-Related Risks & Opportunities

Physical Risks
  • Reduced sales of strongly seasonal products due to unseasonable weather
Transition Risks
  • Burden imposed by carbon tax due to the trend towards reducing greenhouse gases
Opportunities
  • Increased yields of natural raw materials and greater demand for products to help deal with heat

Reporting Standards

Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Products with eco labeling
  • Products using recycled and biomass plastics

Awards & Recognition

  • Not disclosed

Reporting Period: 2021

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Transitioned Sendai Kobayashi Pharmaceutical to zero CO2 emission electricity in 2020
  • Switched to environmentally friendly resins with a low impact on the environment, such as recycled and biomass plastic, starting with top-selling brands Shoshugen and Liquid Bluelet products

Social Achievements

  • Introduced a system allowing side jobs along with liberalization of the dress code in February 2022
  • Held a panel discussion featuring three general managers, entitled “What is diversity promotion?” and converted the content of the discussion into a video
  • Held training for female leaders

Governance Achievements

  • Increased the number of outside directors and created new committees with the aim of improving our governance
  • Established a Nomination Committee and Compensation Advisory Committee
  • Established an Advisory Board

Climate Goals & Targets

Medium-term Goals:
  • Attain consolidated net sales of ¥280 billion in 2030, with ¥90 billion of that amount originating in markets outside of Japan
  • Reduced total CO2 emissions of the Group (Scope 1 and 2) by 51% and of entire supply chain (Scope 3) by 15% compared to 2018 by 2030
Short-term Goals:
  • Raise the percentage of management positions held by women to 16% or higher in 2022

Environmental Challenges

  • Loss of inbound demand due to the spread of the novel coronavirus
  • Reduced production in 2020
  • Increased use of water to prevent snow melting and freezing at some plants
  • Increased production of products that require a lot of water
  • Decreased needs for annual paid holidays owing to the COVID-19 pandemic
  • Limited in-store floor space presents a challenge for OTC sales channels
  • High percentage of products susceptible to seasonality
Mitigation Strategies
  • Used water flow meters to control water consumption and reused water from water purification systems
  • Maintained a high recycling rate of 99.9%
  • Improving flexible work programs
  • Boosting investment in advertising, focusing on strong international businesses
  • Increased investment in research and development
  • Deploying unmanned and automated equipment
  • Strengthening profits at each business, and improving capital efficiency through dividend increases and share buybacks
  • Leveraging e-commerce for niche products
  • Integrating the Direct Marketing Division and Healthcare Division to strengthen domestic e-commerce and online business strategy
  • Adopting in-house eco standards to further advance efforts to lower the environmental impact of products and operations

Supply Chain Management

Supplier Audits: Survey of 40 major suppliers of raw materials in 2020 and 62 primary (Tier 1) suppliers of raw materials, and 367 secondary (Tier 2) suppliers in 2021

Responsible Procurement
  • Kobayashi Pharmaceutical Basic Procurement Policy

Climate-Related Risks & Opportunities

Physical Risks
  • Increased frequency of flood damage
  • Increased water use
  • Changes in areas where body warmers are sold/market shrinking
  • Cost of relocating factories from low-lying areas
  • Halting of procurement due to extinction
Transition Risks
  • Introduction of carbon tax
  • Carbon credit purchase cost
  • Changes in demand
Opportunities
  • Cost reduction through energy conservation
  • Stable supply due to increased yields
  • Price reductions due to increased yields
  • Creation of new markets due to ethical orientation
  • Increased sales of products to counter heatstroke
  • Sale of emission credits

Reporting Standards

Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation

UN Sustainable Development Goals

  • Leave no one behind

Meeting needs that are too small for mass market business

Sustainable Products & Innovation

  • Products with packaging that meets our eco standards are presented with “ECO” labels

Awards & Recognition

  • Intellectual Property Achievement Award from the Commission of the Japan Patent Office

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Achieved Scope 3 target for CO2 emissions reduction
  • Acquired SBTi validation for GHG emissions reduction targets
  • Introduced ecological standards into new product development in 2021
  • Switched to highly sustainable materials for plastic packaging
  • Used 100% sustainable paper packaging

Social Achievements

  • Launched a special pantyliner for discharge, becoming the first company in Japan to do so
  • Implemented job rotation and training to promote the advancement of women
  • Improved employee job satisfaction and percentage of employees feeling able to work in mentally and physically good condition (based on employee attitude surveys)

Governance Achievements

  • Clarified its attitude and commitment to actively investing in human resources in the form of a promise to its employees
  • Established a five-in-one development system combining R&D, technology development, development planning, brand management, and Central R&D Laboratory support to strengthen competitiveness of existing products
  • Reorganized three departments (Finance and Accounting, Public Relations and IR, and Business Support) under the direct control of the president to increase the speed of decision-making

Climate Goals & Targets

Long-term Goals:
  • Become “Kobayashi Pharmaceutical, perfect for digital manufacturing work” by 2030
Medium-term Goals:
  • Lower GHG emissions by 51% for Scopes 1 and 2, and by 15% for Scope 3 by 2030 (compared to 2018)
  • Create new businesses worth ¥8.0 billion in net sales in FY2030
  • Achieve ¥90 billion in net sales in the International Business by 2030
Short-term Goals:
  • Raise the percentage of management positions held by women to 16% or higher by 2025
  • Maintain the four-year contribution rate of new products at 13% or higher
  • Launch two new digital products in the femtech field within three years

Environmental Challenges

  • Sluggish sales growth of existing products in the domestic market
  • Decreasing number of new product launches
  • High raw material and utility costs
  • Product supply issues due to supply chain disruptions
  • Discrepancy between the Company’s purpose and promises to its employees and its current work methods and corporate culture
Mitigation Strategies
  • Accelerating product development by establishing concurrent, unique themes
  • Strengthening marketing promotions focused on e-commerce
  • Working to build a stable supply system for pharmaceutical products
  • Implementing a Company-wide plan to put the theme of the medium-term management plan, “I make a wish and I make it happen,” into practice
  • Implementing dialogue training for managers and obtaining psychological safety facilitator qualifications for executives

Supply Chain Management

Responsible Procurement
  • CSR procurement
  • Procuring low-carbon raw materials and switching to low-carbon specifications
  • Making procurement locations and raw materials more diverse

Climate-Related Risks & Opportunities

Physical Risks
  • Uncertainty around raw material supply due to natural disasters
  • Decrease in sales of body warmers due to global warming
  • Increase in price of naturally derived materials
Transition Risks
  • Increased cost of container and packaging recycling
  • Avoidance of high-carbon products
  • Taxation on Scope 1 and 2 emissions due to carbon tax introduction
  • Taxation on Scope 3 emissions due to carbon tax introduction
  • Increase in price of environmentally friendly resins
  • Increase in price of renewable energy
  • Transition to environmentally friendly products made by other companies
Opportunities
  • Development of new products to meet the needs from fewer people going out and of the e-commerce market
  • Provide and strengthen exclusive e-commerce products
  • Develop antiperspirants, heatstroke prevention products, and infectious disease prevention products

Reporting Standards

Frameworks Used: International Integrated Reporting Framework, Guidance for Collaborative Value Creation

Certifications: SBTi certification for 1.5°C level GHG emissions reduction targets

Sustainable Products & Innovation

  • Shoshugen SAVON (refillable air freshener)
  • Eyebon eye wash (bottle made with biomass raw materials)